Company news
Exagen Inc. news in 2024
Exagen Inc.'s news releases, calls and decks from 2024, newest first.
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
December 11, 2024
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
November 13, 2024
Exagen Inc. Reports Third Quarter 2024 Results
November 11, 2024
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
October 28, 2024
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
October 20, 2024
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
September 3, 2024
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
August 4, 2024
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 1, 2024
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
July 31, 2024
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
July 21, 2024
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
May 12, 2024
Exagen Announces Campaign for Lupus Awareness Month
May 5, 2024
Exagen to Announce First Quarter 2024 Results on May 13, 2024
April 29, 2024
Exagen Inc. Announces Changes to the Board of Directors
April 25, 2024
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
March 17, 2024
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 7, 2024
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
March 6, 2024
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 29, 2024
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 6, 2024